Lucid Diagnostics Inc. LUCD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.68M | -11.69M | -13.91M | -16.27M | -10.40M |
| Total Depreciation and Amortization | 225.00K | 224.00K | 222.00K | 209.00K | 220.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.09M | 681.00K | 3.30M | 3.52M | -24.00K |
| Change in Net Operating Assets | -5.01M | -515.00K | -1.71M | -45.00K | -692.00K |
| Cash from Operations | -15.55M | -11.30M | -12.10M | -12.58M | -10.89M |
| Capital Expenditure | -17.00K | -21.00K | -215.00K | -51.00K | -28.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -17.00K | -21.00K | -215.00K | -51.00K | -28.00K |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 160.00K | 16.85M | 5.50M | 2.00K | 27.13M |
| Repurchase of Common Stock | -4.00K | 0.00 | -17.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 156.00K | 16.85M | 5.49M | 2.00K | 27.13M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.41M | 5.53M | -6.83M | -12.63M | 16.21M |